BioMarin Pharmaceuticals BMRN Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's total revenue?
- BioMarin Pharmaceuticals (BMRN) reported total revenue of $766.21M in Q1 2026.
- How has BioMarin Pharmaceuticals's total revenue changed year-over-year?
- BioMarin Pharmaceuticals's total revenue increased by 2.8% year-over-year, from $745.15M to $766.21M.
- What is the long-term trend for BioMarin Pharmaceuticals's total revenue?
- Over 4 years (2021 to 2025), BioMarin Pharmaceuticals's total revenue has grown at a 14.9% compound annual growth rate (CAGR), from $1.85B to $3.22B.
- What does total revenue mean?
- The total amount of money generated from sales before any expenses are deducted.
- How do you interpret total revenue?
- An increase indicates successful product adoption and market expansion, while a decrease may signal competitive pressure or loss of market exclusivity.
- How does total revenue compare across companies?
- Standard top-line metric across all pharmaceutical companies, typically benchmarked against peer revenue growth rates.